Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

sanofi winthrop industrie - teriflunomide - išsėtinė sklerozė - selektyvūs imunosupresantai - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

basilea pharmaceutica deutschland gmbh - isavukonazolas - aspergiliozė - cresemba yra nurodyta suaugusiųjų gydymas:invazinės aspergillosismucormycosis pacientams, kuriems amphotericin b yra inappropriateconsideration reikėtų teikti oficialius nurodymus, kaip tinkamai naudoti priešgrybelinis agentų.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

novo nordisk a/s - insulinas aspartas - cukrinis diabetas - drugs used in diabetes, insulins and analogues for injection, fast-acting - suaugusiems, paaugliams ir vaikams nuo 1 metų ir vyresniems cukrinio diabeto gydymas.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

novartis europharm limited - vildagliptinas - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

eli lilly nederland b.v. - insulinas lispro - cukrinis diabetas - narkotikai, vartojami diabetu - suaugusiems ir vaikams, sergantiems cukriniu diabetu, kurie reikalauja insulino palaikyti normalią gliukozės homeostazę, gydyti. humalog taip pat skiriamas pradiniam cukrinio diabeto stabilizavimui.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - cukrinis diabetas - narkotikai, vartojami diabetu - cukrinio diabeto gydymas.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

janssen-cilag international nv - kanagliflozinas - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ir 5.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

novartis europharm limited - vildagliptinas - cukrinis diabetas, 2 tipas - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ir 5. 1, jei yra duomenų apie skirtingus derinius).

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozinas - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - narkotikai, vartojami diabetu - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ir 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.